Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcq

Showing results (191-200 of 267) with videos related to

Pageof 27
Sort By:
European Urology Oncology|July 8, 2026
Molecular Profiling of Urothelial Bladder Cancer: Bridging Tumor Biology and Clinical Decision-makingConstance Thibault, Hélène Blons, Yves Allory, et al.
Cold Spring Harbor Symposia on Quantitative Biology|March 27, 2007
Polymorphic microRNA-target interactions: a novel source of phenotypic variationM Georges, A Clop, F Marcq, et al.
The French Journal of Urology|April 17, 2026
Guidelines from the cancer (CCAFU) and infection disease (CI-AFU) committees of the French association of Urology for the management of adverse events and complications of BCGPriscilla Leon, Laura I Levi, Thibaut Long Depaquit, et al.
Plos One|December 31, 2013
Identification of SLAMF3 (CD229) as an inhibitor of hepatocellular carcinoma cell proliferation and tumour progressionIngrid Marcq, Rémy Nyga, Flora Cartier, et al.
Annals of Surgical Oncology|May 10, 2026
Robot-Assisted Versus Open Bladder Cuff Excision After Radical Nephroureterectomy: A Multicenter Study by the French Urothelial Cancer CommitteePierre-Etienne Gabriel, Thomas Seisen, Evanguelos Xylinas, et al.
World Journal of Urology|December 18, 2016
Improved decision making in intermediate-risk prostate cancer: a multicenter study on pathologic and oncologic outcomes after radical prostatectomyJean Baptiste Beauval, Guillaume Ploussard, Bastien Cabarrou, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 9, 2023
Three-Year Overall Survival of Patients With Advanced Non-Small-Cell Lung Cancers With ≥50% PD-L1 Expression Treated With First-Line Pembrolizumab Monotherapy in a Real-World Setting (ESCKEYP GFPC Study)Chantal Decroisette, Laurent Greillier, Hubert Curcio, et al.
Journal for Immunotherapy of Cancer|September 29, 2024
Anti-metabolite chemotherapy increases LAG-3 expressing tumor-infiltrating lymphocytes which can be targeted by combination immune checkpoint blockadeNicola Principe, Amber-Lee Phung, Kofi L P Stevens, et al.
Journal of Clinical Medicine|April 13, 2024
Treating BCG-Induced Cystitis with Combined Chondroitin and Hyaluronic Acid Instillations in Bladder CancerRenate Pichler, Johannes Stäblein, Andrea Mari, et al.
European Radiology|June 29, 2019
Clinical value of a [18F]-FDG PET-CT muscle-to-muscle SUV ratio for the diagnosis of active dermatomyositisNihal Martis, Philippe Viau, Thierry Zenone, et al.
Pageof 27

Showing results (191-200 of 267) with videos related to

Sort By:
Pageof 27
European Urology Oncology|July 8, 2026
Molecular Profiling of Urothelial Bladder Cancer: Bridging Tumor Biology and Clinical Decision-makingConstance Thibault, Hélène Blons, Yves Allory, et al.
Cold Spring Harbor Symposia on Quantitative Biology|March 27, 2007
Polymorphic microRNA-target interactions: a novel source of phenotypic variationM Georges, A Clop, F Marcq, et al.
The French Journal of Urology|April 17, 2026
Guidelines from the cancer (CCAFU) and infection disease (CI-AFU) committees of the French association of Urology for the management of adverse events and complications of BCGPriscilla Leon, Laura I Levi, Thibaut Long Depaquit, et al.
Plos One|December 31, 2013
Identification of SLAMF3 (CD229) as an inhibitor of hepatocellular carcinoma cell proliferation and tumour progressionIngrid Marcq, Rémy Nyga, Flora Cartier, et al.
Annals of Surgical Oncology|May 10, 2026
Robot-Assisted Versus Open Bladder Cuff Excision After Radical Nephroureterectomy: A Multicenter Study by the French Urothelial Cancer CommitteePierre-Etienne Gabriel, Thomas Seisen, Evanguelos Xylinas, et al.
World Journal of Urology|December 18, 2016
Improved decision making in intermediate-risk prostate cancer: a multicenter study on pathologic and oncologic outcomes after radical prostatectomyJean Baptiste Beauval, Guillaume Ploussard, Bastien Cabarrou, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 9, 2023
Three-Year Overall Survival of Patients With Advanced Non-Small-Cell Lung Cancers With ≥50% PD-L1 Expression Treated With First-Line Pembrolizumab Monotherapy in a Real-World Setting (ESCKEYP GFPC Study)Chantal Decroisette, Laurent Greillier, Hubert Curcio, et al.
Journal for Immunotherapy of Cancer|September 29, 2024
Anti-metabolite chemotherapy increases LAG-3 expressing tumor-infiltrating lymphocytes which can be targeted by combination immune checkpoint blockadeNicola Principe, Amber-Lee Phung, Kofi L P Stevens, et al.
Journal of Clinical Medicine|April 13, 2024
Treating BCG-Induced Cystitis with Combined Chondroitin and Hyaluronic Acid Instillations in Bladder CancerRenate Pichler, Johannes Stäblein, Andrea Mari, et al.
European Radiology|June 29, 2019
Clinical value of a [18F]-FDG PET-CT muscle-to-muscle SUV ratio for the diagnosis of active dermatomyositisNihal Martis, Philippe Viau, Thierry Zenone, et al.
Pageof 27